AzTrials
AzTrials

Cold ExposureNCT05464758

The Effects of Cold Adaptation on Skin Blood Flow, Hand Function, and Comfort in Healthy Adults

A study testing Repeated cold exposure in people with Cold Exposure, run by United States Army Research Institute of Environmental Medicine at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In cold weather environments, blood flow to the extremities is significantly reduced, which severely impairs hand function and induces thermal discomfort. Prolonged or repeated cold exposure elicits an adaptive habituation response that is characterized by blunted skin vasoconstriction and thus may be an effective… Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
Conditions the study is for
Cold Exposure
What is being tested?
Repeated cold exposure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited States
Study dates
1 Aug 2022to 13 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female, age 18-39
  • In good health as determined by OMSO (Office of Medical Support and Oversight)
  • Willing to refrain from exercise and caffeinated or alcoholic beverages for 12 hours before each testing session
  • Willing to refrain from smoking or tobacco use 8 hours before each testing session

Who cannot join

  • History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains).
  • Raynaud's syndrome.
  • Cold-induced asthma/bronchospasm
  • Previous hand/finger injuries that impair dexterity and hand function.
  • Metal hardware (plates/screws) in the forearms and hands.
  • Current use of medications or dietary supplements that could alter cardiovascular, thermoregulatory, or vascular control (e.g., anti-hypertensives, statins).
Show all 11Show fewer
  • Known allergies to medical adhesives.
  • Heart, lung, kidney, muscle, or nerve disorder(s)
  • A planned MRI during the study or within 2 days after completing a cold test.
  • Women who are pregnant, planning to become pregnant, or breastfeeding.
  • Not willing to have small areas of skin on the body shaved (if deemed necessary for attachment of study instrumentation)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • U.S. Army Research Institute of Environmental Medicine

    Natick, Massachusetts, 01760

Other trials in United States

About this study

Official title: The Effects of Cold Habituation on Peripheral Blood Flow, Hand Function, and Thermal Comfort

In cold weather environments, blood flow to the extremities is significantly reduced, which severely impairs hand function and induces thermal discomfort. Prolonged or repeated cold exposure elicits an adaptive habituation response that is characterized by blunted skin vasoconstriction and thus may be an effective strategy to improve peripheral perfusion, reduce thermal discomfort, and maintain hand function during cold weather military operations. Since mission conditions often involve low ambient temperatures, countermeasures that reduce cold-induced decrements in hand function and thermal comfort are important to enhance Warfighter readiness in cold weather battlefield environments. The goals of this study are to 1) evaluate the effectiveness of cold habituation in improving skin blood flow, hand function, and thermal comfort during cold exposure and 2) identify the mechanisms that contribute to improvements in skin blood flow following habituation.

Read the detailed description

Participants (n=15, 18-39 yrs) will complete a preliminary cold air exposure (baseline testing) followed by 8 days of repeated cold air exposures with minimal clothing. The cold exposures will be 2 hours in duration and will be conducted in 8°C (46°F) conditions. Before and after the repeated cold exposures, participants will undergo hand function tests, assessments of thermal comfort, and skin blood flow testing.

Conditions
Cold Exposure
Being tested
Repeated cold exposure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Repeated cold exposureOther

    8 consecutive days of exposure to 8°C air for 120 minutes each day

Study groups in NCT05464758
Study groupRoleWhat they receive
Cold habituationExperimental8-day cold habituation
Receives: Other: Repeated cold exposure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Skin blood flow

    Skin blood flow will be measured using non-invasive laser-Doppler flowmetry probes before and during cold exposure. Output (red blood cell flux) will be divided by mean arterial blood pressure to give an index of cutaneous vascular conductance [CVC, flux/mmHg].

    Measured: 8 days

  2. Skin temperature

    Skin temperatures [in °C] at up to 10 sites on the body will be measured using skin thermistors before and during cold exposure. Hand and foot skin temperatures will also be measured with a thermography imaging camera.

    Measured: 8 days

  3. Manual dexterity - Pegboard

    Pegboard scores will be obtained before and during cold exposure. Scores are the number of pegs placed into the boards.

    Measured: 3 days

  4. Manual dexterity - Minnesota Rate of Manipulation

    Minnesota Rate of Manipulation dexterity scores will be obtained before and during cold exposure. Scores are the time [in seconds] required to move small blocks various distances.

    Measured: 3 days

  5. Hand and finger strength

    Pinch and hand strength [in kg] will be measured using a pinch meter and grip strength device (dynamometer). Participants will complete three pinch strength tests and one grip strength test before and during cold exposure.

    Measured: 3 days

  6. Cold perception

    Ratings of thermal comfort, thermal sensation, and pain perception [in arbitrary units] will be assessed using visual analogue scales before and during cold exposure.

    Measured: 5 days

Secondary outcomes (5)
  1. Metabolic heat production

    Oxygen consumption and carbon dioxide production [ml/kg/min] will be measured using computerized indirect calorimetry before and during cold exposure. Oxygen consumption and carbon dioxide production will be combined to report metabolic heat production in Watts per meter squared.

    Measured: 5 days

  2. Body core temperature

    Body core temperature [in °C] will be measured using a telemetry pill self-inserted as a suppository during cold exposure.

    Measured: 5 days

  3. Blood pressure

    Brachial artery blood pressure [in mmHg] will be measured using an automated blood pressure cuff before and during cold exposure.

    Measured: 12 days

  4. Plasma norepinephrine

    Circulating concentrations of norepinephrine [in pg/ml] will be assessed in blood collected via venipuncture before and after cold exposure.

    Measured: 3 days

  5. Heart rate

    Heart rate [in beats per min] will be measured using an automated cuff before and during cold exposure.

    Measured: 12 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2022
  2. Study start1 Aug 2022
  3. Primary completion13 Sep 2024
  4. Study completion13 Sep 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05464758
Sponsor's protocol ID
21-04H
Other IDs
MO210025
Status last verified
Dec 2025
First submitted
6 Jul 2022
Last updated
26 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Repeated cold exposure in people with Cold Exposure, run by United States Army Research Institute of Environmental Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Skin blood flow (time frame: 8 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in